RAD51 and breast cancer: Interestingly, an opposite effect of reduced BC risk in BRCA1-5382insC carriers who also carry the RAD51-135c was recently reported (OR=0.23; 95% CI, 0.07–0.62; P=0.0015, Jakubowska et al, 2003).